Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease

被引:20
作者
Rosler, N [1 ]
Wichart, I [1 ]
Jellinger, KA [1 ]
机构
[1] LAINZ HOSP,LUDWIG BOLTZMANN INST CLIN NEUROBIOL,A-1130 VIENNA,AUSTRIA
关键词
cerebrospinal fluid; apolipoprotein E; Alzheimer's disease;
D O I
10.1136/jnnp.60.4.452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Using a specific enzyme linked immunosorbent assay (ELISA) method, total apolipoprotein E immunoreactivity (tApoE-IR) was measured in premortem lumbar CSF and serum of patients with ''probable'' Alzheimer's disease and in postmortem ventricular CSF of patients with Alzheimer's disease confirmed by necropsy. Concentrations were compared with those from patients with other neurological diseases and controls. The mean serum:lumbar CSF ratio of ApoE-IR was 15.9 suggesting that the main portion of lumbar ApoE-IR is synthesised intrathecally. No significant differences in ApoE-IR between patients with Alzheimer's disease and the other groups were detected in either CSF compartment. In lumbar CSF, there was no correlation between ApoE-IR of patients with Alzheimer's disease and their mini mental stare scores. These results suggest that the diagnostic value of ApoE-IR measurements in CSF of patients with Alzheimer's disease as a single determination is less than that of other markers, in particular tau protein. On the other hand, ApoE determinations could be useful as part of a neurochemical profile of Alzheimer's disease.
引用
收藏
页码:452 / 454
页数:3
相关论文
共 17 条
[1]   CEREBROSPINAL-FLUID APOLIPOPROTEIN-E IS REDUCED IN ALZHEIMERS-DISEASE [J].
BLENNOW, K ;
HESSE, C ;
FREDMAN, P .
NEUROREPORT, 1994, 5 (18) :2534-2536
[2]  
BRAAK H, 1991, ACTA NEUROPATHOL, V82, P306
[3]   CLINICAL RELEVANCE OF THE QUANTIFICATION OF APOLIPOPROTEIN-E IN CEREBROSPINAL-FLUID [J].
CARLSSON, J ;
ARMSTRONG, VW ;
REIBER, H ;
FELGENHAUER, K ;
SEIDEL, D .
CLINICA CHIMICA ACTA, 1991, 196 (2-3) :167-176
[4]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[5]   CLINICAL-NEUROPATHOLOGICAL CORRELATIONS IN ALZHEIMERS-DISEASE AND RELATED DEMENTIAS [J].
GALASKO, D ;
HANSEN, LA ;
KATZMAN, R ;
WIEDERHOLT, W ;
MASLIAH, E ;
TERRY, R ;
HILL, R ;
LESSIN, P ;
THAL, LJ .
ARCHIVES OF NEUROLOGY, 1994, 51 (09) :888-895
[6]   INCREASED LEVELS OF TAU-PROTEIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE - CORRELATION WITH DEGREE OF COGNITIVE IMPAIRMENT [J].
HOCK, C ;
GOLOMBOWSKI, S ;
NASER, W ;
MULLERSPAHN, F .
ANNALS OF NEUROLOGY, 1995, 37 (03) :414-415
[7]   CLINICOPATHOLOGICAL ANALYSIS OF DEMENTIA DISORDERS IN THE ELDERLY [J].
JELLINGER, K ;
DANIELCZYK, W ;
FISCHER, P ;
GABRIEL, E .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 95 (03) :239-258
[8]   DIAGNOSIS OF ALZHEIMERS-DISEASE [J].
KHACHATURIAN, ZS .
ARCHIVES OF NEUROLOGY, 1985, 42 (11) :1097-1104
[9]  
MARTINOLI MG, 1996, IN PRESS ACTA NEUROP
[10]   APOLIPOPROTEIN-E IMMUNOREACTIVITY IN CEREBRAL AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE AND KURU PLAQUE AMYLOID IN CREUTZFELDT-JAKOB DISEASE [J].
NAMBA, Y ;
TOMONAGA, M ;
KAWASAKI, H ;
OTOMO, E ;
IKEDA, K .
BRAIN RESEARCH, 1991, 541 (01) :163-166